{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:09:34Z","timestamp":1778962174088,"version":"3.51.4"},"reference-count":104,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.eimce.2021.04.009","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T07:06:05Z","timestamp":1650697565000},"page":"195-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiology, prevention and control of pertussis in Spain: New vaccination strategies for lifelong protection"],"prefix":"10.1016","volume":"40","author":[{"given":"Juan Jos\u00e9","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"\u00c1lvarez Alde\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Jos\u00e9","family":"\u00c1lvarez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Campins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Garc\u00e9s-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Gil-Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M\u00aa","family":"Grande-Tejada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2021.04.009_bib0525","unstructured":"European Centre for Disease Prevention and Control. Pertussis. In: ECDC. Annual epidemiological report for 2018; 2020. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/pertussis-annual-epidemiological-report-2018."},{"key":"10.1016\/j.eimce.2021.04.009_bib0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajic.2016.03.033","article-title":"Underdetection and underreporting of pertussis in children attended in primary health care centers: do surveillance systems require improvement?","author":"Solano","year":"2016","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.eimce.2021.04.009_bib0535","series-title":"Commission Implementing Decision 2018\/945\/EU of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions","author":"Parliament","year":"2018"},{"key":"10.1016\/j.eimce.2021.04.009_bib0540","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jinf.2017.08.008","article-title":"Assessment of clinical symptoms in household contacts of confirmed pertussis cases","volume":"75","author":"Dominguez","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.eimce.2021.04.009_bib0545","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00431-013-2228-8","article-title":"Incidence of whooping cough in Spain (1997\u20132010): an underreported disease","volume":"173","author":"Fernandez-Cano","year":"2014","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.eimce.2021.04.009_bib0550","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/14760584.2018.1445530","article-title":"Controlling pertussis: how can we do it? A focus on immunization","volume":"17","author":"Martinon-Torres","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.eimce.2021.04.009_bib0555","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.puhe.2018.09.001","article-title":"Monitoring public interest toward pertussis outbreaks: an extensive Google Trends-based analysis","volume":"165","author":"Gianfredi","year":"2018","journal-title":"Public Health"},{"key":"10.1016\/j.eimce.2021.04.009_bib0560","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12889-019-6448-3","article-title":"Does the economic recession influence the incidence of pertussis in a cosmopolitan European city?","volume":"19","author":"Brugueras","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.eimce.2021.04.009_bib0565","first-page":"590","article-title":"Red de Vigilancia Epidemiol\u00f3gica de la Comunidad V","volume":"31","author":"Gil-Tomas","year":"2013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimce.2021.04.009_bib0570","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.vaccine.2018.01.070","article-title":"Effectiveness of acellular pertussis vaccine and evolution of pertussis incidence in the community of Madrid from 1998 to 2015","volume":"36","author":"Latasa","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.eimce.2021.04.009_bib0575","first-page":"309","article-title":"Increase in the number of diagnosed cases of whooping cough; do we think more in it?","volume":"49","author":"Martinez Lorenzo","year":"2017","journal-title":"Aten Primaria"},{"key":"10.1016\/j.eimce.2021.04.009_bib0580","first-page":"20","article-title":"Early intervention in pertussis outbreak with high attack rate in cohort of adolescents with complete acellular pertussis vaccination in Valencia, Spain, April to May 2015","author":"Miguez Santiyan","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.eimce.2021.04.009_bib0585","first-page":"91","article-title":"Outbreak of Whooping cough in 2016, Ecija, Seville, Spain","author":"Porras-Povedano","year":"2017","journal-title":"Rev Esp Salud Publica"},{"key":"10.1016\/j.eimce.2021.04.009_bib0590","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1099\/jmm.0.079756-0","article-title":"Evaluation of reported cases of pertussis: epidemiological study in a large city in Spain","volume":"63","author":"Solano","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.eimce.2021.04.009_bib0595","unstructured":"Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III. Resultados de la vigilancia Epidemiol\u00f3gica de las enfermedades transmisibles. Informe anual. A\u00f1os 2017\u20132018. Madrid, 2020."},{"key":"10.1016\/j.eimce.2021.04.009_bib0600","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.eimc.2013.04.007","article-title":"Pertussis in fully vaccinated infants and children. Are new vaccination strategies required?","volume":"32","author":"Moraga-Llop","year":"2014","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimce.2021.04.009_bib0605","unstructured":"Centro Nacional de Epidemiolog\u00eda. CIBERESP. ISCIII. RENAVE. Situaci\u00f3n de la Tos ferina en Espa\u00f1a, 1998\u20132016. An\u00e1lisis preliminar del Impacto de la Vacunaci\u00f3n de Tos ferina en embarazadas. Madrid, 25 de abril de 2018."},{"key":"10.1016\/j.eimce.2021.04.009_bib0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139993","article-title":"Characteristics of hospitalized cases of pertussis in Catalonia and Navarra. Two regions in the North of Spain","author":"Crespo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.eimce.2021.04.009_bib0615","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1016\/j.vaccine.2019.09.017","article-title":"Paediatric hospitalizations due to whooping cough in Spain (1997\u20132017)","volume":"37","author":"Gil-Prieto","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.eimce.2021.04.009_bib0620","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S0950268813000071","article-title":"Pertussis resurgence: waning immunity and pathogen adaptation \u2013 two sides of the same coin","volume":"142","author":"Mooi","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.eimce.2021.04.009_bib0625","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/cid\/ciu788","article-title":"Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage","volume":"60","author":"Martin","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0630","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10096-014-2297-2","article-title":"Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998\u20132012","volume":"34","author":"van Gent","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0635","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1080\/22221751.2019.1694395","article-title":"Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986\u20132015","volume":"8","author":"Mir-Cros","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.eimce.2021.04.009_bib0640","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00083-15","article-title":"Pertussis: microbiology, disease treatment, and prevention","volume":"29","author":"Kilgore","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimce.2021.04.009_bib0645","article-title":"Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT)","author":"Lee","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.eimce.2021.04.009_bib0650","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3201\/eid2311.170960","article-title":"Emergence of Bordetella holmesii as a causative agent of Whooping Cough, Barcelona, Spain","volume":"23","author":"Mir-Cros","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0655","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(14)70021-0","article-title":"Bordetella holmesii: an under-recognised Bordetella species","volume":"14","author":"Pittet","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0660","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3201\/eid1811.111544","article-title":"Lack of cross-protection against Bordetella holmesii after pertussis vaccination","volume":"18","author":"Zhang","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0665","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/cid\/cis302","article-title":"Clinical definitions of pertussis: summary of a Global Pertussis Initiative roundtable meeting, February 2011","volume":"54","author":"Cherry","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0670","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/CMR.00031-15","article-title":"Laboratory diagnosis of pertussis","volume":"28","author":"van der Zee","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimce.2021.04.009_bib0675","first-page":"1","article-title":"Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines","volume":"54","author":"Tiwari","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.eimce.2021.04.009_bib0680","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid1806.120091","article-title":"Macrolide-resistant Bordetella pertussis infection in newborn girl, France","volume":"18","author":"Guillot","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0685","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7883\/yoken.JJID.2019.421","article-title":"The first report of isolation of macrolide-resistant Bordetella pertussis in Japan","volume":"73","author":"Yamaguchi","year":"2020","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0690","doi-asserted-by":"crossref","first-page":"O825","DOI":"10.1111\/1469-0691.12671","article-title":"High prevalence of erythromycin-resistant Bordetella pertussis in Xi\u2019an, China","volume":"20","author":"Wang","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimce.2021.04.009_bib0695","article-title":"Variation in Bordetella pertussis susceptibility to erythromycin and virulence-related genotype changes in China (1970\u20132014)","author":"Yang","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.eimce.2021.04.009_bib0700","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4161\/hv.34364","article-title":"Pertussis","volume":"11","author":"Gabutti","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eimce.2021.04.009_bib0705","series-title":"Plotkin's Vaccines","article-title":"44 \u2013 Pertussis vaccines","author":"Edwards","year":"2018"},{"key":"10.1016\/j.eimce.2021.04.009_bib0710","first-page":"58","article-title":"A comparative efficacy trial in Germany in which infants received either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) vaccine or DT vaccine","volume":"89","author":"Stehr","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.eimce.2021.04.009_bib0715","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/CVI.00469-09","article-title":"Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis","volume":"17","author":"Cherry","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.eimce.2021.04.009_bib0720","first-page":"CD001478","article-title":"Acellular vaccines for preventing whooping cough in children","author":"Zhang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eimce.2021.04.009_bib0725","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0264-410X(02)00770-3","article-title":"Systematic review of the effects of pertussis vaccines in children","volume":"21","author":"Jefferson","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.eimce.2021.04.009_bib0730","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0264-410X(97)00100-X","article-title":"A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal","volume":"15","author":"Simondon","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.eimce.2021.04.009_bib0735","unstructured":"Pertussis surveillance in Sweden: Nineteen-year report; 2016. https:\/\/www.folkhalsomyndigheten.se\/contentasset\/65ed8fdbdab4999bc358fcd9b657e77\/pertussis-sweden-nineteen-year-report.pdf."},{"key":"10.1016\/j.eimce.2021.04.009_bib0740","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3389\/fimmu.2019.01344","article-title":"Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines","volume":"10","author":"Esposito","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.eimce.2021.04.009_bib0745","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cid\/ciz205","article-title":"How important is the type of acellular pertussis vaccine?","volume":"70","author":"Harriman","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0750","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: adverse reactions","volume":"96","author":"Decker","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimce.2021.04.009_bib0755","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1345\/aph.1M468","article-title":"New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV\/Hib (Pentacel)","volume":"44","author":"Johns","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.eimce.2021.04.009_bib0760","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/14760584.2017.1268920","article-title":"DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers","volume":"16","author":"Lee","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.eimce.2021.04.009_bib0765","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/14760584.2019.1690457","article-title":"DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age","volume":"18","author":"Obando-Pacheco","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.eimce.2021.04.009_bib0770","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1586\/erv.11.72","article-title":"A DTaP-IPV\/\/PRP approximately T vaccine (Pentaxim): a review of 16 years\u2019 clinical experience","volume":"10","author":"Plotkin","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.eimce.2021.04.009_bib0775","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40272-019-00353-7","article-title":"DTaP-IPV-HepB-Hib vaccine (Hexyon((R)): an updated review of its use in primary and booster vaccination","volume":"21","author":"Syed","year":"2019","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.eimce.2021.04.009_bib0780","series-title":"Report from the SAGE Working Group on Pertussis vaccines. Vaccines. 26\u201327 August 2014 meeting, Geneva Switzerland","year":"2014"},{"key":"10.1016\/j.eimce.2021.04.009_bib0785","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3389\/fimmu.2020.01282","article-title":"Global perspectives on immunization during pregnancy and priorities for future research and development: an international consensus statement","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.eimce.2021.04.009_bib0790","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2015.10.100","article-title":"Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study","volume":"34","author":"Maertens","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.eimce.2021.04.009_bib0795","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciw027","article-title":"Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis","volume":"62","author":"Eberhardt","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0800","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.3389\/fimmu.2019.02423","article-title":"The effect of timing of tetanus-diphtheria-acellular pertussis vaccine administration in pregnancy on the avidity of pertussis antibodies","volume":"10","author":"Abu-Raya","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.eimce.2021.04.009_bib0805","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4219","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","author":"Donegan","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.eimce.2021.04.009_bib0810","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12879-020-4824-3","article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review","volume":"20","author":"Vygen-Bonnet","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0815","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.vaccine.2015.12.046","article-title":"Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007\u20132013","volume":"34","author":"Kharbanda","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.eimce.2021.04.009_bib0820","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.vaccine.2013.11.104","article-title":"The relationship between concentration of specific antibody at birth and subsequent response to primary immunization","volume":"32","author":"Jones","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.eimce.2021.04.009_bib0825","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/INF.0b013e3182a09b6a","article-title":"Immune responses in infants whose mothers received Tdap vaccine during pregnancy","volume":"32","author":"Hardy-Fairbanks","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimce.2021.04.009_bib0830","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/cid\/civ695","article-title":"Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator","volume":"61","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0835","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1093\/cid\/ciw551","article-title":"The effect of maternal pertussis immunization on infant vaccine responses to a booster pertussis-containing vaccine in Vietnam","volume":"63","author":"Maertens","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib0840","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/INF.0000000000001601","article-title":"Pneumococcal immune response in infants whose mothers received tetanus diphtheria and acellular pertussis vaccination during pregnancy","volume":"36","author":"Maertens","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimce.2021.04.009_bib0845","doi-asserted-by":"crossref","first-page":"e20164091","DOI":"10.1542\/peds.2016-4091","article-title":"Effectiveness of vaccination during pregnancy to prevent infant pertussis","volume":"139","author":"Baxter","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimce.2021.04.009_bib0850","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.eimce.2021.04.009_bib0855","unstructured":"Grupo de Trabajo tos ferina 2015 de la Ponencia de Programa y Registro de Vacunaciones. Adenda al programa de vacunaci\u00f3n frente a tos ferina en Espa\u00f1a: vacunaci\u00f3n en el embarazo. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad. Servicios Sociales e Igualdad. https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/comoTrabajamos\/docs\/Adenda_TosFerinaEmbarazo.pdf."},{"key":"10.1016\/j.eimce.2021.04.009_bib0860","unstructured":"CAV-AEP. Calendario de Vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Razones y bases de las recomendaciones 2020. [Internet]. Madrid: AEP. 2020. https:\/\/vacunasaep.org\/sites\/vacunasaep.org\/files\/calvacaep2020-razones-y-bases_v.1.3.pdf."},{"key":"10.1016\/j.eimce.2021.04.009_bib0865","unstructured":"Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad. Calendario com\u00fan de vacunaci\u00f3n a lo largo de toda la vida. Calendario recomendado a\u00f1o 2020. https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario-y-coberturas\/docs\/CalendarioVacunacion_Todalavida.pdf."},{"key":"10.1016\/j.eimce.2021.04.009_bib0870","unstructured":"Ministerio de Sanidad. Coberturas de vacunaci\u00f3n. Datos estad\u00edsticos, 2018. https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario-y-coberturas\/coberturas\/home.htm."},{"key":"10.1016\/j.eimce.2021.04.009_bib0875","unstructured":"World Health Organization. Pertussis vaccines: WHO position paper \u2013 September 2015. Wkly Epidemiol Rec. 2015;90:433\u201358."},{"key":"10.1016\/j.eimce.2021.04.009_bib0880","unstructured":"Comit\u00e9 Asesor de Vacunas (CAV-AEP). Tosferina. Manual de vacunas en l\u00ednea de la AEP [Internet]. Madrid: AEP; ene\/2020. http:\/\/vacunasaep.org\/documentos\/manual\/cap-39 [accessed 2.11.20]."},{"key":"10.1016\/j.eimce.2021.04.009_bib0885","unstructured":"European Centre for Disease Prevention and Control. Vaccine schedules in all countries of the European Union. https:\/\/vaccine-schedule.ecdc.europa.eu\/ [accessed 18.03.21]."},{"key":"10.1016\/j.eimce.2021.04.009_bib0890","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/INF.0b013e3181f43906","article-title":"Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in Australia","volume":"30","author":"Foxwell","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimce.2021.04.009_bib0895","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jamapediatrics.2018.2349","article-title":"Immunogenicity and safety of monovalent acellular pertussis vaccine at birth: a randomized clinical trial","volume":"172","author":"Wood","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.eimce.2021.04.009_bib0900","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/14760584.2019.1604230","article-title":"Update on vaccination of preterm infants: a systematic review about safety and efficacy\/effectiveness Proposal for a position statement by Italian Society of Pediatric Allergology and Immunology jointly with the Italian Society of Neonatology","volume":"18","author":"Chiappini","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.eimce.2021.04.009_bib0905","unstructured":"Grupo de trabajo vacunaci\u00f3n en prematuros de la Ponencia de Programa y Registro de Vacunaciones. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Consumo y Bienestar Social. Vacunaci\u00f3n en prematuros, noviembre 2019. https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/enfermedades\/docs\/Vacunacion_Prematuros.pdf."},{"key":"10.1016\/j.eimce.2021.04.009_bib0910","unstructured":"Comit\u00e9 Asesor de Vacunas (CAV-AEP). Fichas t\u00e9cnicas de las vacunas frente a la tosferina. AEP [Internet]; 2020. https:\/\/vacunasaep.org\/profesionales\/fichas-tecnicas-vacunas\/resultados?diseases=155 [accessed 14.11.20]."},{"key":"10.1016\/j.eimce.2021.04.009_bib0915","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.15585\/mmwr.mm6945a7","article-title":"Routine vaccination coverage \u2013 worldwide, 2019","volume":"69","author":"Chard","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.eimce.2021.04.009_bib0920","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/21645515.2016.1259780","article-title":"Immune persistence after pertussis vaccination","volume":"13","author":"Chen","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eimce.2021.04.009_bib0925","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1542\/peds.2014-1729","article-title":"Duration of pertussis immunity after DTaP immunization: a meta-analysis","volume":"135","author":"McGirr","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimce.2021.04.009_bib0013","doi-asserted-by":"crossref","first-page":"E399","DOI":"10.1503\/cmaj.160193","article-title":"Effectiveness of pertussis vaccination and duration of immunity","volume":"188","author":"Schwartz","year":"2016","journal-title":"CMAJ"},{"key":"10.1016\/j.eimce.2021.04.009_bib0935","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.33321\/cdi.2014.38.34","article-title":"Australian vaccine preventable disease epidemiological review series: pertussis, 2006\u20132012","volume":"38","author":"Pillsbury","year":"2014","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.eimce.2021.04.009_bib0940","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning protection after fifth dose of acellular pertussis vaccine in children","volume":"367","author":"Klein","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimce.2021.04.009_bib0945","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jamapediatrics.2019.0711","article-title":"Duration of immunity and effectiveness of diphtheria-tetanus-acellular pertussis vaccines in children","volume":"173","author":"Domenech de Celles","year":"2019","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.eimce.2021.04.009_bib0950","unstructured":"World Health Organization. Diphtheria vaccine: WHO position paper \u2013 August 2017. Releve epidemiologique hebdomadaire. 2017;92:417\u201335."},{"key":"10.1016\/j.eimce.2021.04.009_bib0955","unstructured":"European Center for Disease Prevention and Control. Scientific panel on childhood immunisation schedule: Diphtheria-tetanus-pertussis (DTP) vaccination. [Internet]; 2009. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/publications\/Publications\/0911_GUI_Scientific_Panel_on_Childhood_Immunisation_DTP.pdf."},{"key":"10.1016\/j.eimce.2021.04.009_bib0960","doi-asserted-by":"crossref","first-page":"e15281","DOI":"10.1097\/MD.0000000000015281","article-title":"The effectiveness and safety of pertussis booster vaccination for adolescents and adults: a systematic review and meta-analysis","volume":"98","author":"Xu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eimce.2021.04.009_bib0965","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/21645515.2018.1509646","article-title":"Economic evaluation of adolescents and adults\u2019 pertussis vaccination: a systematic review of current strategies","volume":"15","author":"Fernandes","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eimce.2021.04.009_bib0970","doi-asserted-by":"crossref","first-page":"f4249","DOI":"10.1136\/bmj.f4249","article-title":"Effectiveness of pertussis vaccines for adolescents and adults: case\u2013control study","volume":"347","author":"Baxter","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.eimce.2021.04.009_bib0975","article-title":"Immunisation schedule of the Spanish Association of Paediatrics: 2020 recommendations","volume":"92","author":"\u00c1lvarez Garc\u00eda","year":"2020","journal-title":"Anales de pediatria (Barcelona, Spain: 2003)"},{"key":"10.1016\/j.eimce.2021.04.009_bib0980","unstructured":"Centers for Disease, Control and Prevention. Immunization schedules. https:\/\/www.cdc.gov\/vaccines\/schedules\/index.html."},{"key":"10.1016\/j.eimce.2021.04.009_bib0985","unstructured":"Grupo de trabajo de la Ponencia de Programa y Registro de Vacunaciones. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad SSe. Vacunaci\u00f3n en trabajadores sanitarios. 2017. https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/programasDeVacunacion\/docs\/Vacunacion_sanitarios.pdf."},{"key":"10.1016\/j.eimce.2021.04.009_bib0990","unstructured":"Comit\u00e9 Asesor de Vacunas (CAV-AEP). Vacunaciones del personal sanitario. Manual de vacunas en l\u00ednea de la AEP (Internet). Madrid: AEP; 2020. http:\/\/vacunasaep.org\/documentos\/manual\/cap-19."},{"key":"10.1016\/j.eimce.2021.04.009_bib0995","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of tetanus toxoid reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the advisory committee on immunization practices \u2013 United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.eimce.2021.04.009_bib1000","unstructured":"Grupo de trabajo vacunaci\u00f3n en poblaci\u00f3n adulta y grupos de riesgo de la Ponencia de Programa y Registro de Vacunaciones. Vacunaci\u00f3n en poblaci\u00f3n adulta. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Consumo y Bienestar Social. Published date September 2018. https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/programasDeVacunacion\/docs\/Vacunacion_poblacion_adulta.pdf."},{"key":"10.1016\/j.eimce.2021.04.009_bib1005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/INF.0000000000000486","article-title":"Evaluation of the impact of a pertussis cocooning program on infant pertussis infection","volume":"34","author":"Healy","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimce.2021.04.009_bib1010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/ciu821","article-title":"A case\u2013control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012\u20132013","volume":"60","author":"Dabrera","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib1015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/cid\/ciw634","article-title":"Effectiveness of prenatal versus postpartum tetanus diphtheria, and acellular pertussis vaccination in preventing infant pertussis","volume":"64","author":"Winter","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2021.04.009_bib1020","doi-asserted-by":"crossref","first-page":"30545","DOI":"10.2807\/1560-7917.ES.2017.22.22.30545","article-title":"A case\u2013control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, Valencian community Spain, 1 March 2015 to 29 February 2016","volume":"22","author":"Bellido-Blasco","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.eimce.2021.04.009_bib1025","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.vaccine.2018.02.047","article-title":"Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case\u2013control study","volume":"36","author":"Saul","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.eimce.2021.04.009_bib1030","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1016\/j.vaccine.2019.03.049","article-title":"The effectiveness of maternal pertussis vaccination in protecting newborn infants in Brazil: a case\u2013control study","volume":"37","author":"Fernandes","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.eimce.2021.04.009_bib1035","doi-asserted-by":"crossref","first-page":"e01207","DOI":"10.1016\/j.heliyon.2019.e01207","article-title":"Effectiveness of dTpa vaccination during pregnancy in preventing whooping cough in infants under 3 months of age. Bizkaia, Basque Country, Spain","volume":"5","author":"Sancho-Uriarte","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.eimce.2021.04.009_bib1040","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/cid\/ciz217","article-title":"Maternal vaccination in argentina: tetanus diphtheria, and acellular pertussis vaccine effectiveness during pregnancy in preventing pertussis in infants <2 months of age","volume":"70","author":"Romanin","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X22000570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X22000570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:50:18Z","timestamp":1778961018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X22000570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":104,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2529993X22000570"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2021.04.009","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, prevention and control of pertussis in Spain: New vaccination strategies for lifelong protection","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2021.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}